Furthermore, targeting of a pro-apoptotic peptide to prohibitin in the adipose vasculature caused ablation of white fat, providing a potential basis for the design of a novel anti-obesity treatment. The gene discussed is PHB1; the disease is obesity due to melanocortin 4 receptor deficiency.